| Dr Patricia Ingham Overhulser, MD | |
|
750 Ne 13th St, Oklahoma City, OK 73104-5010 | |
| (405) 235-0040 | |
| Not Available |
| Full Name | Dr Patricia Ingham Overhulser |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 38 Years |
| Location | 750 Ne 13th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053318162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 17776 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Oklahoma City, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oklahoma Allergy And Asthma Clinic | 5294710927 | 12 |
News Archive
Using a polymer that has both water-soluble and water-insoluble regions, a team of investigators from the Siteman Center of Cancer Nanotechnology Excellence has created a nanoparticle shaped like a bialy, a close relative of the bagel. Combining this nanoparticle with manganese, a metal that boosts magnetic resonance imaging signals, and an antibody that targets blood vessels, the investigators then created a new type of imaging agent that also has the potential to deliver drugs to tumors.
COVID-19 is shown to impact the heart and, in some cases, have long-lasting cardiac effects. To discover the extent to which COVID-19 affects the heart, cardiologists and researchers with the University of Miami Miller School of Medicine have begun multiple studies.
New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down's syndrome.
Researchers have uncovered the gene at the root of a human blood group that has remained a mystery for the past 60 years. They showed that a genetic deletion on this gene is responsible for the lack of this blood group in some people.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced the Company received clearance from the Food and Drug Administration (FDA) to market its proprietary BOSS™ bipolar sintered steel coagulation device. The BOSS™ is the latest device based on Bovie's saline enhanced sintered steel technology.
› Verified 1 days ago
| Entity Name | Oklahoma Allergy & Asthma Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861599094 PECOS PAC ID: 5294710927 Enrollment ID: O20040618000611 |
News Archive
Using a polymer that has both water-soluble and water-insoluble regions, a team of investigators from the Siteman Center of Cancer Nanotechnology Excellence has created a nanoparticle shaped like a bialy, a close relative of the bagel. Combining this nanoparticle with manganese, a metal that boosts magnetic resonance imaging signals, and an antibody that targets blood vessels, the investigators then created a new type of imaging agent that also has the potential to deliver drugs to tumors.
COVID-19 is shown to impact the heart and, in some cases, have long-lasting cardiac effects. To discover the extent to which COVID-19 affects the heart, cardiologists and researchers with the University of Miami Miller School of Medicine have begun multiple studies.
New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down's syndrome.
Researchers have uncovered the gene at the root of a human blood group that has remained a mystery for the past 60 years. They showed that a genetic deletion on this gene is responsible for the lack of this blood group in some people.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced the Company received clearance from the Food and Drug Administration (FDA) to market its proprietary BOSS™ bipolar sintered steel coagulation device. The BOSS™ is the latest device based on Bovie's saline enhanced sintered steel technology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia Ingham Overhulser, MD 750 Ne 13th St, Oklahoma City, OK 73104-5010 Ph: (405) 235-0040 | Dr Patricia Ingham Overhulser, MD 750 Ne 13th St, Oklahoma City, OK 73104-5010 Ph: (405) 235-0040 |
News Archive
Using a polymer that has both water-soluble and water-insoluble regions, a team of investigators from the Siteman Center of Cancer Nanotechnology Excellence has created a nanoparticle shaped like a bialy, a close relative of the bagel. Combining this nanoparticle with manganese, a metal that boosts magnetic resonance imaging signals, and an antibody that targets blood vessels, the investigators then created a new type of imaging agent that also has the potential to deliver drugs to tumors.
COVID-19 is shown to impact the heart and, in some cases, have long-lasting cardiac effects. To discover the extent to which COVID-19 affects the heart, cardiologists and researchers with the University of Miami Miller School of Medicine have begun multiple studies.
New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down's syndrome.
Researchers have uncovered the gene at the root of a human blood group that has remained a mystery for the past 60 years. They showed that a genetic deletion on this gene is responsible for the lack of this blood group in some people.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced the Company received clearance from the Food and Drug Administration (FDA) to market its proprietary BOSS™ bipolar sintered steel coagulation device. The BOSS™ is the latest device based on Bovie's saline enhanced sintered steel technology.
› Verified 1 days ago
Ira N Targoff, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 825 Ne 10th St, Oupb 2300, Oklahoma City, OK 73104 Phone: 405-271-8478 Fax: 405-271-4230 | |
Martha M Tarpay, MD Allergy & Immunology Medicare: May Accept Medicare Assignments Practice Location: 4200 W Memorial Rd, Suite 206, Oklahoma City, OK 73120 Phone: 405-752-0393 Fax: 405-752-4242 | |
Dr. Amy L. Darter, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1810 E Memorial Rd, Oklahoma City, OK 73131 Phone: 405-607-4333 Fax: 405-607-4404 | |
Dr. Dean Alan Atkinson, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 750 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-235-0040 Fax: 405-235-4495 | |
Dr. James Howard Wells, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 750 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-235-0040 Fax: 405-235-4495 | |
Dr. John Russell Bozalis, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 750 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-235-0040 Fax: 405-235-4495 |